Can't see share price dropping much below 1.5/6 as this company...

Can't see share price dropping much below 1.5/6 as this company is majority owned by top 20 shareholders who cant/won't get out at these prices.
Recent share fluctuations due to small shareholders trying something else. Dzong sounds bitter and probably should be as think he paid too much, as most including myself have. Good news for this minow is that they have some cash coming in and despite negative talk Thromboview is still very much a game changer for this company. Saying this I think company needs some more positive news on Thromboview progress within the next coming months otherwise minor shareholders may give in.
What is a concern is that if Thromboview is a game changer why arent the larger fish looking at it as an easy takeover, this would be the best outcome I feel for agenix to move forward with this product.